Russia Proposed Legislation to Completely Ban E-Cigarettes Sales

Regulations by 2FIRSTS.ai
Apr.09.2024
Russia Proposed Legislation to Completely Ban E-Cigarettes Sales
Four major Russian political parties propose legislation to ban the sale of e-cigarettes in Russia, citing health concerns and rising youth use.

According to a report by TASS on April 9, four major political parties in Russia, including the Communist Party, the Liberal Democratic Party of Russia, "A Just Russia - For the Truth," and "New People," have jointly proposed legislation to completely ban the sale of e-cigarettes, whether they contain nicotine or not, in Russia.

 

The draft clearly prohibits the retail sale of products containing nicotine or its derivatives, including nicotine salts, as well as e-liquids containing nicotine and those without nicotine, along with related products. According to the main drafter of the legislation, Yaroslav Nilov (LDPR), in an interview with TASS, signatures and consultations in support of the bill are currently being collected, and it is expected to be submitted to the Russian State Duma for review in the near future.

 

The author of the bill cited data in the article showing that, as of 2023, the number of adolescents using e-cigarettes has increased tenfold compared to 2011. The article also notes that while e-cigarettes are promoted as a safer alternative to traditional cigarettes, "it will cause irreparable damage to the health of smokers and those around smokers." Additionally, both e-cigarette users and traditional cigarette smokers will develop nicotine dependence.

 

The authors of the bill pointed out that even e-liquids without nicotine are harmful, as they are composed of glycerin, propylene glycol, flavorings, and thickeners. They also warned that each of these substances could potentially cause serious lung diseases when inhaled in vapor form. In addition, they reminded that even though there are already some restrictions in the e-cigarette industry in Russia, such as prohibiting the sale of e-cigarettes to minors, selling nicotine products with added flavorings and other additives, displaying and demonstrating nicotine consumption devices in public places, and selling e-cigarettes and accessories in markets, exhibitions, and remotely.

 

However, they believe that these bans "can easily be circumvented, and minors can still purchase e-cigarettes."

 

Finally, the author of the bill stressed that "in order to protect the people, we believe it is necessary to comprehensively ban the sale of e-cigarettes at the federal level. While this ban may lead to losses in the federal budget, protecting the health of the nation, especially the youth, is more important for the future of our country. As for the potential increase in the risk of illegal e-cigarette trade, this is a matter that law enforcement agencies will need to address."

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10
IMF Article Sets Out Three Principles: Cover All Harmful Products, Match Tax Rates to Harm, Improve Cross-Border Coordination
IMF Article Sets Out Three Principles: Cover All Harmful Products, Match Tax Rates to Harm, Improve Cross-Border Coordination
A March 2026 article in Finance & Development, “Taxing Harmful Habits,” argues that taxes on harmful products such as tobacco, alcohol and sugary drinks should better reflect the health harm they cause. The authors propose three principles: capture all harmful products, align tax rates with health harm, and strengthen cross-border coordination to reduce evasion and smuggling.
Mar.24 by 2FIRSTS.ai
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
Research Summary | NHANES Study: Smoking or E-Cigarette Use Linked to Higher Prevalence of Elevated Blood Pressure and Hypertension
A cross-sectional analysis based on the US NHANES 2021–2023 cycle, including 6,262 participants aged over 12, found that compared with people who neither smoke nor vape, those who smoke and/or use e-cigarettes had a higher prevalence of elevated blood pressure and hypertension. After full adjustment, smoking/vaping was associated with elevated blood pressure (aOR 1.34) and hypertension (aOR 1.46), and with a 1.05 mmHg higher diastolic blood pressure.
Feb.09 by 2FIRSTS.ai
Five Inner West Sydney shops shut for 90 days after 780,000 illicit cigarettes and 2,200 illegal vapes seized
Five Inner West Sydney shops shut for 90 days after 780,000 illicit cigarettes and 2,200 illegal vapes seized
NSW Health has shut down five Inner West Sydney stores for 90 days after a major seizure of illicit cigarettes and illegal vapes, with two additional premises in Northern NSW also served closure notices. The action forms part of a broader crackdown that has seen 66 stores closed since new laws took effect in late 2025, with NSW Health warning further enforcement — including prosecution — may follow.
Feb.09 by 2FIRSTS.ai
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Special Report | Breeze and Glas Seek White House Review as FDA Advances Flavored ENDS Guidance
Breeze Smoke and Glas, Inc. have separately requested White House review under Executive Order 12866 as the FDA advances draft guidance on flavored ENDS (RIN 0910-ZC78). The guidance aims to clarify evidentiary standards under the statutory “appropriate for the protection of public health” (APPH) framework. The parallel filings highlight industry concern over regulatory predictability, particularly as Glas’s PMTA review status has recently drawn market attention.
Special Report
Mar.03
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
Special Report|FDA Revises Device Name in Glas Vape Authorization; Company Signals Optimism on Menthol, Flavored Pods
The FDA updated public records on the PMTA authorization of a Glas vape product, renaming “Glas G Device” to “Glas G² Device” and releasing the order letter detailing scientific review and marketing restrictions. Company disclosures suggest the platform may include age-verification technology. If confirmed, Glas G² could be the first vape with device-level age verification to receive an FDA MGO. Glas executives also said menthol and other flavored pods could gain authorization in the future.
Special Report
Mar.14